170 related articles for article (PubMed ID: 35935816)
1. Class IIa histone deacetylase inhibition ameliorates acute kidney injury by suppressing renal tubular cell apoptosis and enhancing autophagy and proliferation.
Li J; Yu C; Shen F; Cui B; Liu N; Zhuang S
Front Pharmacol; 2022; 13():946192. PubMed ID: 35935816
[TBL] [Abstract][Full Text] [Related]
2. Class IIa HDAC inhibitor TMP195 alleviates lipopolysaccharide-induced acute kidney injury.
Zhang W; Guan Y; Bayliss G; Zhuang S
Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1015-F1026. PubMed ID: 33017186
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Class IIa HDACs improves endothelial barrier function in endotoxin-induced acute lung injury.
Kovacs-Kasa A; Kovacs L; Cherian-Shaw M; Patel V; Meadows ML; Fulton DJ; Su Y; Verin AD
J Cell Physiol; 2021 Apr; 236(4):2893-2905. PubMed ID: 32959895
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of class IIa histone deacetylase activity by gallic acid, sulforaphane, TMP269, and panobinostat.
Choi SY; Kee HJ; Jin L; Ryu Y; Sun S; Kim GR; Jeong MH
Biomed Pharmacother; 2018 May; 101():145-154. PubMed ID: 29482060
[TBL] [Abstract][Full Text] [Related]
5. Effects of novel HDAC inhibitors on urothelial carcinoma cells.
Kaletsch A; Pinkerneil M; Hoffmann MJ; Jaguva Vasudevan AA; Wang C; Hansen FK; Wiek C; Hanenberg H; Gertzen C; Gohlke H; Kassack MU; Kurz T; Schulz WA; Niegisch G
Clin Epigenetics; 2018 Jul; 10(1):100. PubMed ID: 30064501
[TBL] [Abstract][Full Text] [Related]
6. Class I HDAC activity is required for renal protection and regeneration after acute kidney injury.
Tang J; Yan Y; Zhao TC; Gong R; Bayliss G; Yan H; Zhuang S
Am J Physiol Renal Physiol; 2014 Aug; 307(3):F303-16. PubMed ID: 24808536
[TBL] [Abstract][Full Text] [Related]
7. Hypoxic mesenchymal stem cells ameliorate acute kidney ischemia-reperfusion injury via enhancing renal tubular autophagy.
Tseng WC; Lee PY; Tsai MT; Chang FP; Chen NJ; Chien CT; Hung SC; Tarng DC
Stem Cell Res Ther; 2021 Jun; 12(1):367. PubMed ID: 34183058
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological inhibition of SMYD2 protects against cisplatin-induced acute kidney injury in mice.
Cui B; Hou X; Liu M; Li Q; Yu C; Zhang S; Wang Y; Wang J; Zhuang S; Liu F
Front Pharmacol; 2022; 13():829630. PubMed ID: 36046818
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological inhibition of the mixed lineage leukemia 1-menin interaction aggravates acute kidney injury induced by folic acid and ischemia-reperfusion in mice.
Hou X; Cui B; Qiu A; Liu N; Zhuang S
Am J Physiol Renal Physiol; 2023 Nov; 325(5):F669-F680. PubMed ID: 37733875
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of class IIa histone deacetylases alleviates renal fibrosis.
Xiong C; Guan Y; Zhou X; Liu L; Zhuang MA; Zhang W; Zhang Y; Masucci MV; Bayliss G; Zhao TC; Zhuang S
FASEB J; 2019 Jul; 33(7):8249-8262. PubMed ID: 30951378
[TBL] [Abstract][Full Text] [Related]
11. Dynamic changes in histone deacetylases following kidney ischemia-reperfusion injury are critical for promoting proximal tubule proliferation.
Hyndman KA; Kasztan M; Mendoza LD; Monteiro-Pai S
Am J Physiol Renal Physiol; 2019 May; 316(5):F875-F888. PubMed ID: 30810062
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase D1 mediates class IIa histone deacetylase phosphorylation and nuclear extrusion in intestinal epithelial cells: role in mitogenic signaling.
Sinnett-Smith J; Ni Y; Wang J; Ming M; Young SH; Rozengurt E
Am J Physiol Cell Physiol; 2014 May; 306(10):C961-71. PubMed ID: 24647541
[TBL] [Abstract][Full Text] [Related]
13. The Class IIA Histone Deacetylase (HDAC) Inhibitor TMP269 Downregulates Ribosomal Proteins and Has Anti-Proliferative and Pro-Apoptotic Effects on AML Cells.
Urwanisch L; Unger MS; Sieberer H; Dang HH; Neuper T; Regl C; Vetter J; Schaller S; Winkler SM; Kerschbamer E; Weichenberger CX; Krenn PW; Luciano M; Pleyer L; Greil R; Huber CG; Aberger F; Horejs-Hoeck J
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831382
[TBL] [Abstract][Full Text] [Related]
14. Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling.
Liu N; He S; Ma L; Ponnusamy M; Tang J; Tolbert E; Bayliss G; Zhao TC; Yan H; Zhuang S
PLoS One; 2013; 8(1):e54001. PubMed ID: 23342059
[TBL] [Abstract][Full Text] [Related]
15. Blockade of histone deacetylase 6 protects against cisplatin-induced acute kidney injury.
Tang J; Shi Y; Liu N; Xu L; Zang X; Li P; Zhang J; Zheng X; Qiu A; Zhuang S
Clin Sci (Lond); 2018 Feb; 132(3):339-359. PubMed ID: 29358506
[TBL] [Abstract][Full Text] [Related]
16. Class I histone deacetylase activity is required for proliferation of renal epithelial cells.
Tang J; Yan Y; Zhao TC; Bayliss G; Yan H; Zhuang S
Am J Physiol Renal Physiol; 2013 Aug; 305(3):F244-54. PubMed ID: 23698124
[TBL] [Abstract][Full Text] [Related]
17. JMJD3 activation contributes to renal protection and regeneration following acute kidney injury in mice.
Yu C; Tang J; Yu J; Wang Y; Liu N; Dong Z; Zhuang S
FASEB J; 2024 Apr; 38(7):e23583. PubMed ID: 38551634
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of HDAC6 protects against rhabdomyolysis-induced acute kidney injury.
Shi Y; Xu L; Tang J; Fang L; Ma S; Ma X; Nie J; Pi X; Qiu A; Zhuang S; Liu N
Am J Physiol Renal Physiol; 2017 Mar; 312(3):F502-F515. PubMed ID: 28052874
[TBL] [Abstract][Full Text] [Related]
19. Lithium targeting of AMPK protects against cisplatin-induced acute kidney injury by enhancing autophagy in renal proximal tubular epithelial cells.
Bao H; Zhang Q; Liu X; Song Y; Li X; Wang Z; Li C; Peng A; Gong R
FASEB J; 2019 Dec; 33(12):14370-14381. PubMed ID: 31661633
[TBL] [Abstract][Full Text] [Related]
20. FOXO3a Activation by HDAC Class IIa Inhibition Induces Cell Cycle Arrest in Pancreatic Cancer Cells.
Usami M; Kikuchi S; Takada K; Ono M; Sugama Y; Arihara Y; Hayasaka N; Nakamura H; Ikeda Y; Hirakawa M; Yoshida M; Miyanishi K; Kobune M; Kato J
Pancreas; 2020 Jan; 49(1):135-142. PubMed ID: 31856089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
